DAIICHI SANKYO, INC.
- Country
- ๐บ๐ธUnited States
- Ownership
- Subsidiary
- Established
- 2010-01-01
- Employees
- 10K
- Market Cap
- $79B
- Website
- http://daiichisankyo.us
DX-8951f in Treating Patients With Biliary Cancer
- Conditions
- First Posted Date
- 2004-04-20
- Last Posted Date
- 2012-05-16
- Lead Sponsor
- Daiichi Sankyo
- Registration Number
- NCT00005938
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
๐บ๐ธUniversity of Colorado Cancer Center, Denver, Colorado, United States
๐บ๐ธSimmons Cancer Center - Dallas, Dallas, Texas, United States
DX-8951f in Treating Patients With Liver Cancer
- Conditions
- First Posted Date
- 2004-04-16
- Last Posted Date
- 2012-05-16
- Lead Sponsor
- Daiichi Sankyo
- Registration Number
- NCT00004108
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
๐บ๐ธUniversity of Colorado Cancer Center, Denver, Colorado, United States
๐บ๐ธCancer Therapy & Research Center, San Antonio, Texas, United States
Chemotherapy in Treating Women With Metastatic Breast Cancer
- Conditions
- First Posted Date
- 2004-04-15
- Last Posted Date
- 2012-05-16
- Lead Sponsor
- Daiichi Sankyo
- Registration Number
- NCT00004046
- Locations
- ๐บ๐ธ
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
Chemotherapy in Treating Patients With Prostate Cancer
- Conditions
- First Posted Date
- 2004-04-15
- Last Posted Date
- 2012-05-16
- Lead Sponsor
- Daiichi Sankyo
- Registration Number
- NCT00004045
- Locations
- ๐บ๐ธ
U.S. Oncology Research Inc., Houston, Texas, United States
๐บ๐ธInstitute for Drug Development, San Antonio, Texas, United States
DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma
- Conditions
- First Posted Date
- 2004-04-08
- Last Posted Date
- 2012-05-16
- Lead Sponsor
- Daiichi Sankyo
- Registration Number
- NCT00080834
- Locations
- ๐บ๐ธ
MD Anderson Cancer Center at University of Texas, Houston, Texas, United States
๐บ๐ธUniversity of New Mexico Cancer Research and Treatment Center, Albuquerque, New Mexico, United States
DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors
- Conditions
- First Posted Date
- 2004-02-11
- Last Posted Date
- 2012-05-16
- Lead Sponsor
- Daiichi Sankyo
- Registration Number
- NCT00077077
- Locations
- ๐บ๐ธ
Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, Alabama, United States
๐บ๐ธCancer Therapy and Research Center, San Antonio, Texas, United States
๐บ๐ธBarbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
- Conditions
- First Posted Date
- 2003-07-09
- Last Posted Date
- 2012-05-16
- Lead Sponsor
- Daiichi Sankyo
- Registration Number
- NCT00064220
- Locations
- ๐บ๐ธ
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
๐ต๐ทVeterans Affairs Medical Center - San Juan, San Juan, Puerto Rico
๐บ๐ธIndiana University Cancer Center, Indianapolis, Indiana, United States
Soblidotin in Treating Patients With Progressive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Conditions
- First Posted Date
- 2003-06-06
- Last Posted Date
- 2012-05-16
- Lead Sponsor
- Daiichi Sankyo
- Registration Number
- NCT00061854
- Locations
- ๐บ๐ธ
Medical Oncology and Hematology, P.C., Waterbury, Connecticut, United States
๐บ๐ธBarbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
๐บ๐ธMemorial Sloan-Kettering Cancer Center, New York, New York, United States
Exatecan Mesylate in Treating Children With Relapsed or Refractory Rhabdomyosarcoma
- Conditions
- First Posted Date
- 2003-03-07
- Last Posted Date
- 2012-05-16
- Lead Sponsor
- Daiichi Sankyo
- Registration Number
- NCT00055939
- Locations
- ๐บ๐ธ
Medical City Dallas Hospital, Dallas, Texas, United States
๐บ๐ธNemours Children's Clinic, Jacksonville, Florida, United States
๐บ๐ธMemorial Sloan-Kettering Cancer Center, New York, New York, United States
Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor
- Conditions
- First Posted Date
- 2003-03-07
- Last Posted Date
- 2012-05-16
- Lead Sponsor
- Daiichi Sankyo
- Registration Number
- NCT00055952
- Locations
- ๐บ๐ธ
Medical City Dallas Hospital, Dallas, Texas, United States
๐บ๐ธSimmons Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States
๐บ๐ธUniversity of Colorado Cancer Center at University of Colorado Health Sciences Center, Denver, Colorado, United States